SUTRO BIOPHARMA, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $88.8M | $341.4M | $30.4M |
| FY2022 | $189.9M | $406.9M | $47.3M |
| FY2023 | $321.1M | $470.7M | $69.3M |
| FY2024 | $342.6M | $387.2M | $190.3M |
| FY2025 | $306.3M | $173.8M | $58.1M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $88.8M | $341.4M | $30.4M |
| FY2022 | $189.9M | $406.9M | $47.3M |
| FY2023 | $321.1M | $470.7M | $69.3M |
| FY2024 | $342.6M | $387.2M | $190.3M |
| FY2025 | $306.3M | $173.8M | $58.1M |